BioHealth News Archive
Newest Halcyon Incubator Cohort Tackling Top Current Social Issues
Halcyon, a nonprofit dedicated to supporting early-stage social entrepreneurs, today announces its eighth cohort for the Halcyon Incubator program. With an acceptance rate of…
Read MoreIndustry Awards Celebration Nominations Launch Party
Thursday, January 11, 2018 5:00 PM - 7:00 PM, VariQ 2600 Tower Oaks Blvd Suite 300 Rockville, MD 20852 The Maryland Tech Council’s 30th…
Read MoreFinal BioBuzz of 2017 with BHI – December 20th
When: Wednesday, December 20, 2017 from 5:00 PM to 7:00 PM Where: Bar Louie 150 Gibbs St Rockville, MD 20850 Join BioBuzz and annual…
Read MoreThe Washington Business Journal Recognizes Emmes in Two ’Top Company’ Lists
The Emmes Corporation today announced that it was named one of the top women-owned businesses in the Washington metropolitan area by the Washington Business…
Read MoreHHS nominee Alex Azar talks drug pricing and ACA politics – MedCity News
As secretary for the Department of Health and Human Services (HHS), Alex Azar would oversee a trillion-dollar budget, over 90,000 employees, and a healthcare…
Read MoreImmunomic Therapeutics’ Founder Appointed to Maryland Life Sciences Advisory Board | Business Wire
Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company is pleased to announce Immunomic's founder and CEO, William Hearl, Ph.D., has been appointed…
Read MoreMerck and Qiagen to expand in U.K.
U.S. drugmaker Merck & Co. and German diagnostics firm Qiagen are separately planning major investments in the U.K. The moves accompany a raft of…
Read MoreDC Startup News: Tech Startup Funding, Investment in November
In covering the D.C. innovation economy comes the inevitable: funding news. Trust us, there’s a lot of it floating around the D.C. metro area.…
Read MorePhaseBio Enters Worldwide License Agreement with MedImmune for a Reversal Agent for Ticagrelor | Markets Insider
PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced that the Company has entered an exclusive,…
Read MoreMimetas OrganoPlate®
Complex tissues. Surprisingly simple. Enabling you to study complex 3D tissue biology in a simple device, that’s our goal. With perfused vessels, co-culture and…
Read MoreJohns Hopkins researchers crack key part of mystery surrounding proteins
What makes the body of a person or any other organism work can for the most part be summed up in a word: proteins.…
Read MoreMedical firm launches $10M venture capital fund | 2017-11-28 | Grand Rapids Business Journal
A medical device developer has created a $10-million venture capital fund to support early stage health care companies. Holland-based Genesis Innovation Group said today…
Read MoreAvantor® Completes Acquisition of VWR
Avantor, Inc., a global supplier of ultra-high-purity materials for the life sciences and advanced technology industries, today announced the successful completion of its acquisition…
Read MoreWharton and Angel Capital Association Study Changes Perceptions About the Investors Behind U.S. Startup Economy
The American Angel, a new comprehensive national study released today, provides a detailed picture of angel investors, who they are, where they live, and…
Read MoreRoche launches HyperCap Target Enrichment Portfolio, a fully integrated and streamlined NGS sample
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the HyperCap Target Enrichment Portfolio, a streamlined and fully integrated NGS sample preparation. …
Read More